Quantcast
Last updated on April 23, 2014 at 11:40 EDT

Elsevier Launches SciVal Funding App on SciVerse Applications

November 3, 2011

AMSTERDAM, November 3, 2011 /PRNewswire/ –

– App links SciVerse articles and abstracts to SciVal Funding,
increasing discoverability of global funding opportunities

Elsevier, a world-leading provider of scientific, technical and medical
information products and services, today announced the launch of the
SciVal(R) Funding App for SciVerse(R). The app links content from SciVerse
ScienceDirect and SciVerse Scopus with SciVal Funding, Elsevier’s online
solution that provides targeted recommendations on grants, making it easier
for researchers to discover funding opportunities related to their area of
research.

The SciVal Funding App can be subscribed to or added for free in
SciVerse Applications [http://bit.ly/scivalfundingapp ]. It will retrieve up
to five relevant funding opportunities to an abstract in SciVerse Scopus or
SciVerse ScienceDirect. The app uses the Elsevier Fingerprint Engine[TM] to
match active funding opportunities to the abstracts, delivering targeted
funding recommendations directly into the researchers’ workflow.

In addition to the launch of the app, SciVal Funding has expanded its
geographic scope to Australia and Ireland. SciVal Funding now covers the
United States, Canada, United Kingdom, European Union, Australia, and
Ireland. This year more than 1,400 funding bodies have already been added to
the initial 3,000 U.S.-based sources available on the platform. By the end
of the year we aim to include funding bodies from Singapore, South Africa,
and New Zealand.

“We continuously work on finding new ways to help researchers discover a
maximum amount of international funding opportunities in the most practical
way” said Niels Weertman, Vice President SciVal, Elsevier. “Through the
SciVal Funding App more researchers will now be able to benefit from the
virtues of SciVal Funding, while the continued global expansion of SciVal
Funding ensures that researchers will be better equipped to identify the
research funds available internationally.”

About the Elsevier SciVal(R) Suite

Elsevier’s SciVal suite [http://www.info.scival.com ] of services
supports academic and government leadership in evaluating, establishing and
executing research strategies that optimize the performance of existing
assets and maximize investments to enhance near and long-term productivity.
SciVal tools leverage Scopus(R) data, Elsevier’s trusted source of
bibliometric data, to offer innovative yet authoritative solutions. Current
suite offerings include: SciVal Spotlight(TM), a strategic tool that
generates unique institutional and country maps of existing and emerging
research strengths based on an interdisciplinary perspective of current
performance; SciVal Funding(TM), an online solution that provides targeted
recommendations on grants to pursue based on pre-populated research profiles
and historical awards; SciVal Strata(TM), a web-based research performance
tool that offers users the flexibility to construct relevant contextual data
to evaluate research teams or individual researchers, using a range of
indicators based on Scopus data; SciVal Experts, a semantic technology-based
application that enables researchers to identify and locate sources of
expertise at an individual or departmental level within and across
institutions.

About the Elsevier SciVerse Suite
The SciVerse ( http://www.sciverse.com) suite of search and discovery
offerings provides the global research community access to a constantly
expanding universe of content and solutions which can now be accessed in one
platform. The suite currently includes SciVerse ScienceDirect (
http://www.sciencedirect.com), the world’s largest source of
peer-reviewed content containing more than 10 million articles, and SciVerse
Scopus ( http://www.scopus.com), an abstract and citation database
containing 41 million records, 70% with abstracts and nearly 18,000 titles
from 5,000 publishers worldwide. The new platform also includes SciVerse Hub
beta ( http://www.hub.sciverse.com), which enables researchers to
perform a single search across all of the SciVerse content as well as
targeted web content with results ranked by relevancy and without
duplication. SciVerse Applications beta (
http://www.applications.sciverse.com), a new module within the suite, is
a marketplace and developer network that allows the scientific community to
build, find and use applications that enhance the SciVerse research
experience.

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier’s online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.nl ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai’s Pinpoint Review [http://www.medai.com ], which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier
[http://www.elsevier.com ] employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).

        Media contact
        Lindsey Steinseifer
        +1-212-752-8338
        lsteinseifer@psbpr.com

SOURCE Elsevier


Source: PR Newswire